MX2018000166A - Metodos para una mejor administración de agentes activos a tumores. - Google Patents

Metodos para una mejor administración de agentes activos a tumores.

Info

Publication number
MX2018000166A
MX2018000166A MX2018000166A MX2018000166A MX2018000166A MX 2018000166 A MX2018000166 A MX 2018000166A MX 2018000166 A MX2018000166 A MX 2018000166A MX 2018000166 A MX2018000166 A MX 2018000166A MX 2018000166 A MX2018000166 A MX 2018000166A
Authority
MX
Mexico
Prior art keywords
methods
tumors
active agents
agents
better delivery
Prior art date
Application number
MX2018000166A
Other languages
English (en)
Inventor
Frederick Ross Russell
Original Assignee
Kimberly Clark Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kimberly Clark Co filed Critical Kimberly Clark Co
Publication of MX2018000166A publication Critical patent/MX2018000166A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A61M37/0015—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0021—Intradermal administration, e.g. through microneedle arrays, needleless injectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A61M2037/0007—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin having means for enhancing the permeation of substances through the epidermis, e.g. using suction or depression, electric or magnetic fields, sound waves or chemical agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A61M37/0015—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles
    • A61M2037/0023—Drug applicators using microneedles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A61M37/0015—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles
    • A61M2037/0038—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles having a channel at the side surface
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A61M37/0015—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles
    • A61M2037/0061—Methods for using microneedles

Landscapes

  • Health & Medical Sciences (AREA)
  • Dermatology (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Anesthesiology (AREA)
  • Medical Informatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)

Abstract

La presente invención se refiere a la administración de agentes a través de la piel. Los métodos para administrar agentes tales como agentes bioactivos se contemplan en la presente invención. Específicamente, se describen métodos para la administración dirigida de agentes a una o más áreas de la epidermis y, de esta manera, a uno o más tumores de cáncer.
MX2018000166A 2015-07-24 2016-07-22 Metodos para una mejor administración de agentes activos a tumores. MX2018000166A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201562196570P 2015-07-24 2015-07-24
US201562196578P 2015-07-24 2015-07-24
PCT/US2016/043623 WO2017019526A2 (en) 2015-07-24 2016-07-22 Methods for better delivery of active agents to tumors

Publications (1)

Publication Number Publication Date
MX2018000166A true MX2018000166A (es) 2018-03-26

Family

ID=57885141

Family Applications (2)

Application Number Title Priority Date Filing Date
MX2018000166A MX2018000166A (es) 2015-07-24 2016-07-22 Metodos para una mejor administración de agentes activos a tumores.
MX2022014277A MX2022014277A (es) 2015-07-24 2018-01-08 Metodos para una mejor administracion de agentes activos a tumores.

Family Applications After (1)

Application Number Title Priority Date Filing Date
MX2022014277A MX2022014277A (es) 2015-07-24 2018-01-08 Metodos para una mejor administracion de agentes activos a tumores.

Country Status (15)

Country Link
US (3) US10806913B2 (es)
EP (2) EP3925599A1 (es)
JP (1) JP7082041B2 (es)
KR (1) KR20180035209A (es)
CN (1) CN107921248A (es)
AU (3) AU2016297823B2 (es)
BR (1) BR112018001292A2 (es)
CA (1) CA2991455C (es)
DK (1) DK3325080T3 (es)
ES (1) ES2891523T3 (es)
HU (1) HUE056410T2 (es)
MX (2) MX2018000166A (es)
PL (1) PL3325080T3 (es)
RU (1) RU2719943C2 (es)
WO (1) WO2017019526A2 (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107949418B (zh) * 2015-07-24 2024-07-02 索伦托治疗有限公司 用于活性剂的淋巴递送的方法
EP3925599A1 (en) * 2015-07-24 2021-12-22 Sorrento Therapeutics, Inc. Methods for better delivery of active agents to tumors
US11541015B2 (en) 2017-05-17 2023-01-03 Massachusetts Institute Of Technology Self-righting systems, methods, and related components
JP7038739B2 (ja) * 2017-05-17 2022-03-18 マサチューセッツ インスティテュート オブ テクノロジー 自己復元物品
EP3652133A4 (en) 2017-07-10 2021-04-21 Basf Se MIXTURES INCLUDING A UREASE INHIBITOR (IU) AND A NITRIFICATION INHIBITOR SUCH AS 2- (3,4-DIMETHYL-1H-PYRAZOL-1-YL) SUCCINIC ACID (DMPSA) OR 3,4-DIMETHYL PYRAZOLIUM GLYCOLATE (DMPG)
CA3100710A1 (en) 2018-05-17 2019-11-21 Massachusetts Institute Of Technology Systems for electrical stimulation
WO2019232265A1 (en) * 2018-05-31 2019-12-05 Sorrento Therapeutics, Inc. Drug delivery methods targeting the lymphatic system
WO2020064082A1 (en) * 2018-09-24 2020-04-02 L'oreal Device comprising microneedles for skin-coloring
AU2020397052A1 (en) 2019-12-05 2022-07-14 Vivasor, Inc. Method of treating cancer by administration of an anti-PD-1 or anti-PD-L1 therapeutic agent via a lymphatic delivery device
JP2024505198A (ja) 2021-01-22 2024-02-05 ソレント・セラピューティクス・インコーポレイテッド コロナウイルスワクチンのマイクロリットルスケールのリンパ送達のためのデバイス
WO2022192594A2 (en) 2021-03-11 2022-09-15 Sorrento Therapeutics, Inc. Nucleic acid molecules and vaccines comprising same for the prevention and treatment of coronavirus infections and disease
CA3221925A1 (en) 2021-06-09 2022-12-15 Sorrento Therapeutics, Inc. Method of treating cancer by administration of an anti-pd-1 or anti-pd-l1 therapeutic agent via a lymphatic microneedle delivery device
KR20240056524A (ko) 2021-08-18 2024-04-30 소렌토 쎄라퓨틱스, 인코포레이티드 림프계를 표적화하는 치료학적 제제

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE72524B1 (en) 1994-11-04 1997-04-23 Elan Med Tech Analyte-controlled liquid delivery device and analyte monitor
HUP0202592A3 (en) 2000-06-01 2003-07-28 Watson Pharmaceuticals Inc Cor Transdermal delivery of lasofoxifene
AU2002333554C1 (en) * 2001-09-12 2008-12-11 Becton, Dickinson And Company Microneedle-based pen device for drug delivery and method for using same
EP1635876A4 (en) * 2003-06-13 2009-05-06 Becton Dickinson Co IMPROVED INTRADERMAL ADMINISTRATION OF BIOACTIVE AGENTS
MXPA06002159A (es) 2003-08-26 2006-05-22 Becton Dickinson Co Metodos para la administracion intradermica de agentes terapeuticos.
EP1802258A4 (en) 2004-09-13 2015-09-23 Chrono Therapeutics Inc BIOSYNCHRONE TRANSDERMAL MEDICINES
WO2006127962A2 (en) * 2005-05-25 2006-11-30 Becton, Dickinson And Comapny Particulate formulations for intradermal delivery of biologically active agents
EP1893130A4 (en) * 2005-06-17 2015-08-26 Georgia Tech Res Inst COATED MICROSTRUCTURES AND METHOD FOR THE PRODUCTION THEREOF
US8197435B2 (en) * 2006-05-02 2012-06-12 Emory University Methods and devices for drug delivery to ocular tissue using microneedle
EP2100850A1 (en) * 2008-03-11 2009-09-16 Stichting Voor De Technische Wetenschappen Microneedle array and a method for manufacturing microneedles
US8715736B2 (en) * 2009-04-30 2014-05-06 Florida Agricultural And Mechanical University Nanoparticle formulations for skin delivery
CN101829394B (zh) * 2010-04-27 2012-08-22 上海交通大学 台阶微针阵列的制备方法
CN102985131B (zh) 2010-04-28 2016-06-29 金伯利-克拉克环球有限公司 用于递送siRNA的医疗装置
PT2563450T (pt) 2010-04-28 2017-08-28 Kimberly Clark Co Dispositivo para entrega de medicação para a artrite reumatóide
DK2563453T3 (en) 2010-04-28 2017-05-22 Kimberly Clark Co Nano-patterned medical device with improved cellular interaction and process for its preparation
AU2011311255B2 (en) 2010-04-28 2015-10-08 Sorrento Therapeutics, Inc. Method for increasing permeability of an epithelial barrier
US20120187814A1 (en) 2011-01-25 2012-07-26 Fryling Nicholas A Furniture System and a Frame Assembly for a Furniture System
US20120245445A1 (en) * 2011-03-21 2012-09-27 Michael Darryl Black Glucose Monitoring System
CA2852672C (en) 2011-10-17 2021-07-20 Massachusetts Institute Of Technology A microfluidic system and method for delivering a payload into a cell by causing perturbations in a cell membrane of the cell
EP2771059B1 (en) * 2011-10-27 2019-07-17 Sorrento Therapeutics, Inc. Transdermal delivery of high viscosity bioactive agents
KR101575039B1 (ko) 2012-07-19 2015-12-07 (주)아모레퍼시픽 노즐 장치 및 이를 포함하는 최소 침습형 주입 장치
EP2895217B1 (en) * 2012-09-13 2020-10-21 Avraham Amir Delivery devices and methods for skin augmentation
PT2897620T (pt) 2012-09-21 2020-09-03 Intensity Therapeutics Inc Método de tratamento de cancro
CN103157178B (zh) * 2013-02-05 2014-12-31 北京化工大学 精确控制微针插入长度的印章式工具
WO2014132240A1 (en) 2013-02-28 2014-09-04 Kimberly-Clark Worldwide, Inc. Transdermal drug delivery device
EP2961469A4 (en) 2013-02-28 2016-10-26 Kimberly Clark Co DEVICE FOR DELIVERY OF MEDICAMENT
AU2014270014A1 (en) 2013-05-23 2015-12-17 Kimberly-Clark Worldwide, Inc. Microneedles with improved open channel cross-sectional geometries
US10376674B2 (en) * 2014-09-15 2019-08-13 Ethicon, Inc. System and method for targeted delivery of therapeutic agents to tissue
EP3925599A1 (en) * 2015-07-24 2021-12-22 Sorrento Therapeutics, Inc. Methods for better delivery of active agents to tumors
CN107949418B (zh) * 2015-07-24 2024-07-02 索伦托治疗有限公司 用于活性剂的淋巴递送的方法

Also Published As

Publication number Publication date
AU2022275397A1 (en) 2023-01-05
EP3325080A4 (en) 2019-04-17
CA2991455A1 (en) 2017-02-02
WO2017019526A2 (en) 2017-02-02
US10806913B2 (en) 2020-10-20
MX2022014277A (es) 2022-12-07
EP3325080B1 (en) 2021-09-01
AU2021200146A1 (en) 2021-03-18
CN107921248A (zh) 2018-04-17
AU2021200146B2 (en) 2022-08-25
AU2016297823A1 (en) 2018-02-15
ES2891523T3 (es) 2022-01-28
BR112018001292A2 (pt) 2018-09-11
DK3325080T3 (da) 2021-10-04
EP3925599A1 (en) 2021-12-22
HUE056410T2 (hu) 2022-02-28
AU2016297823B2 (en) 2020-10-22
RU2018104102A3 (es) 2019-11-06
JP2018521755A (ja) 2018-08-09
KR20180035209A (ko) 2018-04-05
US20210052871A1 (en) 2021-02-25
US20180193624A1 (en) 2018-07-12
RU2719943C2 (ru) 2020-04-23
RU2018104102A (ru) 2019-08-27
PL3325080T3 (pl) 2022-01-24
EP3325080A2 (en) 2018-05-30
CA2991455C (en) 2023-10-10
JP7082041B2 (ja) 2022-06-07
US20240238570A1 (en) 2024-07-18

Similar Documents

Publication Publication Date Title
MX2022014277A (es) Metodos para una mejor administracion de agentes activos a tumores.
PH12018502429A1 (en) Antibody molecules for cancer treatment
WO2017134302A3 (en) Targeted therapeutic agents and uses thereof
ZA201905488B (en) Tigit- and light-based chimeric proteins
MX2022014634A (es) Metodos para la administracion linfatica de agentes activos.
NZ752526A (en) Pyrrolobenzodiazepine conjugates
MA40437A (fr) Méthodes de traitement du cancer faisant appel à des inhibiteurs de tigit et à des agents anticancéreux
PH12016500871A1 (en) Combination therapy including an mdm2 inhibitor and one or more additional pharmaceutically active agents for the treatment of cancers
PH12019502363A1 (en) Phenyl-2-hydroxy-acetylamino-2-methyl-phenyl compounds
EA201591925A1 (ru) Терапевтические композиции и их применение
PH12016502249A1 (en) Pladienolide pyridine compounds and methods of use
MX2019013808A (es) Compuestos desestabilizadores de microtubulina para usarse en el tratamiento del cancer.
MX2017005861A (es) Metodos para el control transcripcional objetivo en regiones del super mejorador.
MX2016007445A (es) Inhibidores de f1f0-atpasa de trifluorometil pirazolil guanidina y usos terapeuticos de los mismos.
MX2017002388A (es) Composiciones para fibras de queratina.
MY200161A (en) Bacteria for targeting tumors and treating cancer
PH12016501838A1 (en) Compounds and their methods of use
MX2017009608A (es) Compuestos anticancerigenos.
MX2020000636A (es) Proteinas sinteticas y usos terapeuticos de las mismas.
NZ746011A (en) Glycoalkaloid combinations and various uses thereof
MX2018014135A (es) Tratamiento del dolor.
IN2013MU03118A (es)
MX2020002812A (es) Abx196 para usarse en el tratamiento del cancer de vejiga.
EA201992022A1 (ru) Терапевтическая рнк
MA39718A (fr) Compositions et méthodes d'utilisation de celles-ci